188
Results-
NewsA Passionate Medical Science Liaison (MSL) Advancing Healthcare in AustraliaCreated on : - Last modified on :The script of the video:
-
NewsA Passionate Medical Science Liaison (MSL) Advancing Healthcare in PolandCreated on : - Last modified on :
-
NewsDiscover the Pierre Fabre Laboratories 2024 annual report!Created on : - Last modified on :Introduced in the editorial by Eric Ducournau, CEO, “Pierre Fabre: Relentlessly innovating", the annual report this year is organized around our Group signature “New ways to care."
-
NewsPierre Fabre Laboratories on the global stage at two international congresses in September: ESMO and EADVCreated on : - Last modified on :Pierre Fabre Laboratories’ mission is to innovate constantly, particularly in the fields of oncology and dermatology. This mission is accomplished alongside healthcare professionals, the company’s day-to-day partners. Driven by a constant desire to share expertise and present the company’s latest therapeutic innovations, Pierre Fabre teams are taking part in two major events in September: ESMO and EADV.
-
NewsWorld Lymphoma Awareness Day – Understanding Post-Transplant Lymphoproliferative Disorders (PTLD)Created on : - Last modified on :Join us in recognizing World Lymphoma Awareness Day, 15th September, a day dedicated to raising awareness of lymphomas, which are cancers of the lymphocytes or white blood cells. This day sheds light on a type of cancer with more than 80 subtypes and that affects up to 864,000 people world wide1,2. One of these subtypes is Post-Transplant Lymphoproliferative disorder (PTLD).
-
NewsA Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany.Created on : - Last modified on :
-
NewsA Medical Science Liaison (MSL) Transforming the Therapeutic Landscape in China.Created on : - Last modified on :The script of the video.
-
NewsA Medical Science Liaison (MSL) Dedicated to Changing Patient Lives in the United Kingdom.Created on : - Last modified on :The script of the video.
-
NewsLaunch of the Gustave Roussy PrizeCreated on : - Last modified on :An initiative supported by Pierre Fabre Laboratories in favor of scientific innovation in oncology. Villejuif, November 18, 2024 – On the occasion of the 150th anniversary of the birth of Professor Gustave Roussy and approaching the 100th anniversary of the Institute that bears his name, an international prize is being launched to reward scientific innovation in oncology. The Gustave Roussy Prize, endowed with €200,000 per year, aims to honor researchers whose discoveries have a significant impact on the care of cancer patients.
-
NewsMattia Pagnani: A Medical Science Liaison (MSL) Aiming to Enhance Patient Outcomes in ItalyCreated on : - Last modified on :
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.